Aehr Test Systems vs. KLA: Two Very Different AI Chip Bets
Aehr supplies stress-testing gear for silicon carbide and AI memory; KLA sells process control at scale. Both closed higher on Sept. 18 — but they are not the same wager.
Aehr Test Systems (AEHR) closed at 93.49, up 3.25%, and KLA Corporation (KLAC) closed at 176.99, up 4.74%, on Sept. 18, 2026, as investors weighed a small specialist in silicon carbide and AI memory stress-testing against a large process-control incumbent.
Two semiconductor equipment names sit on opposite ends of the same supply chain, and investors keep being asked to choose between them. Aehr Test Systems (AEHR) makes specialized stress-testing equipment aimed at the silicon carbide and artificial intelligence memory markets. KLA Corporation (KLAC) sells process control and yield management systems to essentially every leading-edge fab on earth. One is a focused bet on two fast-moving end markets. The other is a toll booth on chip manufacturing as a whole.
Both finished the session higher on Friday, Sept. 18, 2026. Aehr last traded at 93.49, up 3.25% from a prior close of 90.55, after ranging between 87.15 and 93.90. KLA last traded at 176.99, up 4.74% from a prior close of 168.98, with a day range of 169.72 to 177.14 — a close within a whisker of the session high. Those moves landed on a mixed tape: the Nasdaq 100 proxy QQQ rose 0.63% to $721.45, while the S&P 500 proxy SPY slipped 0.12% to $761.69 and the Dow proxy DIA fell 0.48% to $515.88.
What Aehr Actually Sells, and Why It Is Volatile
Aehr's business is burn-in and stress testing: putting devices under elevated voltage and temperature before they ship, so that the parts most likely to fail early fail in the test cell rather than in a customer's product. That matters most where a field failure is expensive or dangerous — which is precisely the argument for silicon carbide power devices, the material of choice for electric vehicle traction inverters and high-voltage industrial power conversion.
The second leg, per the company's own positioning and as laid out by Nasdaq Markets, is AI memory. Accelerator packages stack enormous quantities of memory next to the logic die, and a single weak stack can compromise an assembly worth far more than the part itself. Screening those devices before assembly is a genuine engineering requirement, not a marketing slide.
The problem with a business built on two concentrated end markets is that it moves like one. Aehr's session tells the story: a low of 87.15 and a high of 93.90 in a single day, with the stock closing at the top of that range. That is not the trading pattern of a broadly diversified industrial supplier. It is the pattern of a small-capitalization name where a handful of customer decisions can reset the full-year revenue picture, and where the market reprices the whole thesis on incremental news.
KLA's Position Is Structural Rather Than Thematic
KLA does not need an AI narrative to justify its place in a fab. Process control — inspection and metrology that finds defects and measures dimensions at every critical step — scales with process complexity. As nodes shrink, as packaging gets three-dimensional, and as chipmakers stack more layers, the number of steps that require verification rises. More steps means more tools, and more tools with higher average selling prices.
That is why KLA's exposure to AI is indirect but durable. It does not matter enormously to KLA whether the winning accelerator architecture comes from one vendor or another, or whether high-bandwidth memory or an alternative wins the next socket. What matters is total leading-edge wafer starts and the complexity of the flows. KLA's 4.74% advance — the larger of the two moves on the day — is the kind of gain that typically reflects sector-wide sentiment on capital equipment rather than company-specific product news.
The trade-off is obvious. A company already embedded across the industry does not double its addressable market because one end application takes off. Incumbency buys resilience; it does not buy the kind of revenue slope that draws growth investors to a specialist.
Reading the Tape on Sept. 18
Friday's session is worth parsing because the index moves disagreed with each other. The Nasdaq 100 proxy was the only major benchmark up on the day, gaining 0.63% and closing at $721.45 against a day range of $715.08 to $721.73 — also near the top of its range. The Dow proxy dropped 0.48%, and the broad S&P 500 proxy was essentially flat with a small loss. In other words, the bid was concentrated in technology, and both semiconductor names participated in it.
Friday's session is worth parsing because the index moves disagreed with each other.
KLA outpaced the Nasdaq 100 proxy by a wide margin on the day, gaining 8.01 points to close at 176.99. Aehr added 2.94 points to reach 93.49. Both figures are simple arithmetic from the session's prior closes and are illustrative of magnitude, not a statement about valuation. The more useful observation is behavioral: on a day when large-cap tech led and the rest of the market did not, capital equipment caught a bid, and the larger, more liquid of the two names got the bigger move. That is often what an index-driven rally looks like — flows reach the widely held name first.
How to Frame the Choice
There is no single right answer here because the two stocks answer different questions.
- If the question is leverage to silicon carbide and AI memory specifically, Aehr is the more direct instrument. Its equipment addresses those markets by design, and a genuine inflection in either would land on a far smaller revenue base.
- If the question is exposure to semiconductor capital intensity in general, KLA is the cleaner vehicle. Process control demand tracks complexity across the entire leading edge, which makes it less dependent on any one application winning.
- If the question is drawdown tolerance, the day's trading ranges are a fair proxy for what each name does in a bad tape. Aehr traveled a wider proportional range than KLA on a day both finished green.
- If the question is position sizing, a concentrated specialist and a diversified incumbent should not be sized the same way, regardless of which one an investor prefers.
What Would Change the Picture
For Aehr, the variables to watch are order flow from silicon carbide device makers and whether AI memory screening converts from a qualification opportunity into repeat volume shipments. Because the base is small, customer concentration cuts both directions: a single large program can transform a year, and its absence can equally define one.
For KLA, the watch items are broader — leading-edge capital expenditure budgets at the handful of customers that drive them, the pace of advanced packaging adoption, and export-control policy, which affects tool shipments to certain geographies for the whole equipment complex.
The comparison is also a reminder that "AI stock" has become a category loose enough to hold two companies with almost nothing in common operationally. One supplies test cells that screen parts for reliability in specific applications. The other sells inspection and metrology into every fab running an advanced process. Both benefit if compute demand keeps rising. They just do not benefit in the same way, on the same timeline, or with the same risk of being wrong.
Key facts
- AEHR last close: 93.49, +3.25% (as of 20:00 GMT, Sept. 18, 2026)
- KLAC last close: 176.99, +4.74% (as of 20:00 GMT, Sept. 18, 2026)
- Aehr's end markets: Silicon carbide power devices and AI memory stress testing
- Benchmark backdrop: QQQ +0.63% to $721.45; SPY -0.12% to $761.69; DIA -0.48% to $515.88
Frequently asked questions
What does Aehr Test Systems actually make?
Aehr supplies specialized stress-testing equipment — burn-in systems that subject semiconductor devices to elevated voltage and temperature before shipment so early-life failures surface in the test cell. Its equipment targets the silicon carbide power device market, used heavily in electric vehicle and industrial power conversion, and the artificial intelligence memory market, where a single weak part can compromise an expensive assembly.
How is KLA Corporation exposed to AI?
KLA's exposure is indirect. It sells process control equipment — inspection and metrology tools that find defects and measure critical dimensions during chip manufacturing. Demand scales with the number and complexity of manufacturing steps rather than with any single end application, so KLA benefits from rising leading-edge wafer starts regardless of which accelerator or memory architecture wins.
How did the two stocks close on Sept. 18, 2026?
Aehr Test Systems (AEHR) last traded at 93.49, up 3.25% from a prior close of 90.55, with a day range of 87.15 to 93.90. KLA Corporation (KLAC) last traded at 176.99, up 4.74% from a prior close of 168.98, ranging between 169.72 and 177.14. Both closed near the top of their sessions.
Which of the two is the more volatile holding?
Aehr is the more concentrated business, dependent on two specific end markets and a relatively small customer base, which historically produces wider price swings. Its Sept. 18 session spanned 87.15 to 93.90 before closing at 93.49. KLA, embedded across the semiconductor industry, traded a proportionally narrower range on the same day.
What was the broader market doing that session?
Technology led while the rest of the market lagged. The Nasdaq 100 proxy QQQ rose 0.63% to $721.45, the S&P 500 proxy SPY slipped 0.12% to $761.69, and the Dow proxy DIA fell 0.48% to $515.88. Both semiconductor equipment names outperformed all three benchmarks on the day.
What should investors watch next for each company?
For Aehr, the key variables are order flow from silicon carbide device manufacturers and whether AI memory screening becomes repeat volume business rather than one-off qualification work. For KLA, the drivers are leading-edge capital expenditure budgets at its largest customers, advanced packaging adoption rates, and export-control policy affecting tool shipments to certain regions.
